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Abstract.  Basic fibroblast growth factor (bFGF) in- 
duces cell proliferation and plasminogen  activator (PA) 
activity in transformed  fetal bovine aortic endothelial 
(FBAE) GM 7373 cells. A  similar response is ob- 
served after treatment with  12-O-tetradecanoylphorbol- 
13-acetate (TPA).  In these cells, bFGF and TPA cause 
activation of protein kinase C  (PKC), as demonstrated 
by the induction of the phosphorylation of an 87-kD 
PKC substrate in intact cells and by the increase in 
membrane-associated PKC activity. Activation of PKC 
by bFGF or TPA is inhibited in cells made PKC- 
deficient by pretreatment  with high concentrations of 
TPA.  The mitogenic activity of bFGF or of TPA is 
completely inhibited in PKC-deficient cells or in naive 
cells treated with the PKC inhibitor H-7. However, 
these cells proliferate in response to serum,  epidermal 
growth factor, and dibutyryl cyclic AMP.  Similar 
results are obtained in normal FBAE AG 7680 cells. 
These data indicate that activation of PKC is responsi- 
ble for the mitogenic activity of bFGF in FBAE cells. 
On the contrary, the PA-inducing activity of bFGF is 
unaffected by down-regulation of PKC or by treatment 
with the PKC inhibitor H-7  in both transformed GM 
7373 and normal AG 7680 cells, bFGF induces a 
rapid 45Ca influx in naive and in PKC-deprived GM 
7373 cells. In these cells, addition of EGTA to the in- 
cubation medium prevents both the 45Ca influx and the 
increase in PA activity induced by bFGF, without 
affecting its mitogenic activity. Even though the in- 
volvement of PKC in the increase of cell-associated PA 
activity induced by bFGF can not be completely dis- 
missed,  the present results suggest a role of calcium 
entry in the modulation of the PA-inducing activity of 
bFGE 
p 
ROTEI~ kinase C  (PKC) ~ is a calcium and phospho- 
lipid-dependent  enzyme that  is activated  by diacyl- 
glycerol (Nishizuka,  1984). Several lines of evidence 
indicate that PKC is involved in mediating  the intracellular 
signaling  that triggers  various biological processes, includ- 
ing  those  elicited  by  certain  polypeptide  growth  factors 
(Nishizuka,  1986). 
Basic fibroblast growth factor (bFGF) is an 18-kD mitogen 
characterized by its affinity for heparin.  In vitro,  it induces 
cell proliferation and a  characteristic  set of responses, in- 
cluding protease production, depending  upon the cell type 
under investigation.  In vivo, bFGF has been shown to induce 
neovascularization  (for a recent review on bFGF see Gospo- 
darowicz et al., 1987). The role exerted by PKC in the trans- 
duction signaling  mediating  bFGF activity is still  unclear. 
bFGF has been shown to activate PKC in Swiss 3T3 and in 
3T3-L1  fibroblasts  (Blackshear et al.,  1985;  Tsuda  et al., 
1. Abbreviations used in this paper: bFGE basic fibroblast growth factor; 
db-cAMP, dibutyryl cyclic AMP; FBAE, fetal bovine aortic endothelial; 
H-7,  I-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride;  PA, 
plasminogen activator; PKC, protein kinase C. 
1985; Kaibuchi et al.,  1986). Down-regulation  of PKC has 
been shown  to decrease but not to abolish,  the ability of 
bFGF to stimulate cell proliferation  (Huang et al., 1988) and 
to increase ornithine  decarboxylase, c-fos, c-myc, and beta- 
actin mRNA levels in 3T3 cells (Hovis et al., 1986; Kaibuchi 
et al.,  1986;  Stumpo and Blackshear,  1986).  On the other 
hand,  PKC activation  was not detectable after treatment of 
Chinese hamster lung CCL39 fibroblasts  with bFGF (Mag- 
naldo et al., 1986). Moreover, bFGF has been shown to pro- 
mote phosphorylation of  proteins of  22 and 31 kD and to acti- 
vate  a  ribosomal $6 protein  kinase  in  3T3-L1 fibroblasts 
made PKC-deficient by long-term treatment with phorbol es- 
ter (Blackshear  et al.,  1985;  Pelech et al.,  1986). 
In cultured bovine capillary endothelial  cells, bFGF in- 
duces plasminogen  activator  (PA) and collagenase produc- 
tion, motility, and cell proliferation  (Moscatelli et al., 1986; 
Presta et al.,  1986). Preliminary experiments  performed in 
our laboratory had shown that transformed  fetal bovine aor- 
tic endothelial (FBAE) GM 7373 cells respond to a 24-h treat- 
ment with bFGF with a  10--20-fold increase in PA activity 
and with a 70-80% increase in cell number (see below). The 
high and rapid response of GM 7373 cells to bFGF prompted 
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and to assess the role of PKC in the transmodulation signal- 
ing responsible for the mitogenic activity and for the PA- 
inducing activity of bFGE 
The results  indicate that bFGF induces proliferation of 
GM 7373 cells via PKC activation. Induction of PA activity 
by bFGF is instead independent of PKC and it appears to be 
triggered by calcium uptake from the extracellular environ- 
ment. Similar results were obtained in an isolate of normal 
FBAE cells,  thus  confirming the positive role exerted by 
PKC in the regulation of cell proliferation in FBAE cells. 
Materials and Methods 
Cell Cultures 
GM 7373 and AG 7680 cells were obtained from the National Institute of 
General Medical Sciences Human Genetic Mutant Cell Repository (Insti- 
tute for  Medical  Research,  Camden,  NJ).  GM  7373  ceils represent an 
immortalized cell line which was derived from FBAE cells by in vitro trans- 
formation with benzo(a)pyrene and correspond to the BFA-lc IBPT mul- 
tilayered transformed clone described by Grinspan et al. (1983). AG 7680 
cells are an isolate of normal FBAE cells. GM 7373 cells were grown in 
MEM containing 10% FCS, vitamins, and essential and nonessential amino 
acids. AG 7680 calls were grown in the same conditions except that FCS 
concentration was 20%. 
Cell Proliferation Assay 
The assay was performed on subconfluent cells. To this purpose, GM 7373 
or  AG  7680  cells  were  plated  in  24-well  dishes at  70000  or  50,000 
cells/cm  2,  respectively.  After  24  h,  cultures  were  washed  twice  with 
serum-free medium and incubated in fresh medium containing 0.4% FCS 
and different concentrations of human recombinant bFGF (obtained from 
Synergen Inc., Boulder, CO) or of other molecules. 24 h later, cells were 
washed twice with PBS, trypsinized, and counted by using a Burker cham- 
ber. Cultures incubated in fresh medium containing 10%  FCS were used 
as positive controls. For both normal and transformed cells, this treatment 
resulted in an 80-100% increase of the cell number in respect to cells in- 
cubated in 0.4%  FCS with no addition. 
Plasminogen Activator Assay 
GM 7373 or AG 7680 cells were seeded in 96-well dishes at the same density 
used for the cell proliferation assay. After 24 h, cells were washed twice 
with serum-free medium and incubated in fresh medium containing 0.4% 
FCS and different concentrations of bFGF or of other molecules. 24 h later, 
cell-associated  PA  activity  was  measured.  To  this  purpose,  cells  were 
washed twice with PBS and were extracted with  100/~1  of 0.05%  Triton 
X-100 in 60 mM Tris-HCl, pH 8.5 (TIT buffer). Aliqnots of the cell extracts 
corresponding to 1 ~g of protein were incubated in a microtiter plate with 
4.2 ng of purified glu-plasminogen (Kabi AB, Stockholm, Sweden) and 42 
nmol of the plasmin chromogenic substrate H-D-norleucyl-hexahydrotyrosyl- 
lysine-p-nitroanilide-acetate (American Diagnostica,  Greenwich,  CT)  in 
150 #1 of T/T buffer. After incubation at 37"C, the plate was read at 405 
nm with an automatic microplate reader.  Human urokinase (Calbiochem- 
Behring Corp., La Jolla, CA) was used as a  standard. 
Down-Regulation of  PKC 
Long-term treatment with high concentrations of phorbol ester results in 
down-regulation of PKC in several cell types (Rodriguez-Pena and Rozen- 
gurt,  1984;  Rozengurt,  1986;  Wolfman et al.,  1987).  Accordingly, sub- 
confluent cultures of GM 7373 or AG 7680 cells were incubated for 16 h 
in fresh medium containing 0.4%  FCS and 3 p.g/ml 12-O-tetradecanoyl- 
phorbol-13-acetate (TPA). This treatment results in down-regulation of PKC 
(see Results). In all the experiments, control cultures, herewith referred to 
as naive cultures, were incubated in the same medium with 0.4% FCS and 
solvent control. In untreated PKC-deprived cells, cell-associated PA activity 
was identical to that detectable in untreated naive cultures. Routinely, to 
evaluate the response of PKC-deprived cells to mitogenic and PA-inducing 
stimuli, naive and PKC-deficient cells were further incubated for  16 h  in 
fresh medium containing 0.4%  FCS and the molecule tested.  Then, cell 
proliferation and cell-associated PA activity were determined as described 
above. It must be pointed out that no difference in the response of PKC- 
deprived cells to the mitogens tested was observed when the molecules were 
added directly to the medium containing TPA, i.e., without medium change, 
or when the mitogens were administered in fresh medium in the presence 
or in the absence of 3 ttg/ml TPA (results not shown). 
PKC Assay 
Subconfluent GM 7373 ceils were incubated for 16 h in fresh medium con- 
taining 0.4% FCS. Then, cells were washed with serum-free medium and 
incubated for 5 min at 37*C in serum-free medium containing solvent con- 
trol, 30 ng/ml bFGF, or  10 ng/ml TPA. Then, incubation was terminated 
by washing the cells twice with ice cold PBS and scraped with a  rubber 
policeman in homogenization buffer which contained 10 mM Hepes buffer 
(pH 7.5),  10 mM 2-mercaptoethanoi, 5  mM EDTA, 0.24 M  sucrose, 75 
/~g/ml PMSF,  110 mU/ml aprotinin, 50/~g/ml leupeptin, and 4 #g/ml pep- 
statin.  Harvested cells were  sonicated on ice  with six  10-s bursts each 
preceded by 10-s pause. Homogenates were centrifuged at 100,000 g for 60 
min at 4"C. The supernatant and the particulate fraction were the cytosolic 
and  membrane fractions,  respectively.  Membranes were  resuspended in 
homogenization buffer containing 1% NP-40, held at 4"C for 1 h, and cen- 
trifuged at 13,000 g for 15 min at 4°C to separate detergent-solubilized mate- 
rial. PKC assay on 500-txg aliquots of solubilized membrane fractions was 
performed as described (Thomas et al., 1987), using 250/zg/ml historic III- 
S (Sigma Chemical Co., St.  Louis, MO) as exogenous substrate. 
Labeling of Cells with 32p~ 
Subconfluent GM 7373 cells were incubated for 16 h in fresh medium con- 
taining 0.4%  FCS. Then, cultures were washed twice with DME without 
phosphate and incubated for 1 h in the same medium. The medium was re- 
moved and the cells were incubated for 3 h at 37°C with DME phosphate- 
free containing 50 t~Ci/ml  carrier-free 32pi to label endogenous ATP pool. 
Then, 100 ng/ml TPA, 100 ng/ml bFGE or solvent control were added for 
various times ranging from 15 s to  10 min. The reaction was stopped by 
removing the medium and rapidly washing the cultures twice with ice-cold 
0.15 M NaCI in 20 mM Tris-HCI, pH 7.5. The cells were immediately ex- 
tracted with 5% "[CA at 4°C for 30 min. The acid-soluble materials were 
removed; the precipitated proteins were washed twice and dissolved with 
150 ~l of SDS-PAGE reducing sample buffer heated at 100°C. The samples 
were then transferred to tubes and placed in boiling water bath for 5  min 
before resolution by SDS-8%  PAGE. Then, gels were exposed to Kodak 
X-Omat AR film for 1-12 h. 87-kD phosphorylation was quantified by soft- 
laser scanning of the autoradiography of the gel Similar results were ob- 
tained when the 87-kD protein was excised from the gel and counted for ra- 
dioactivity in a  scintillation counter. 
'JCa Uptake in GM 7373 Cells 
Subconfluent cells  in  35-mm dishes were  incubated  for  16  h  in  fresh 
medium containing 0.4% FCS with solvent control or 3/Lg/ml TPA. Then, 
cells  were  washed with  serum-free medium and  added  with  the  same 
medium containing 2  /zCi/ml 4~Ca (14.5  mCi/mg calcium) and different 
concentrations of bFGE After various times, the cells were washed rapidly 
five times with ice-cold PBS and extracted with 5% TCA at 4°C for 30 min. 
TCA-soluble material was then collected and counted for radioactivity in a 
liquid  scintillation counter.  Radioactivity  measured in  the TCA-soluble 
material of cells incubated with 4SCa for 5  s at 4°C represented nonspe- 
cifically bound Ca  2+ and was subtracted from all the values. 
Results 
Induction of  Plasminogen Activator Activity and 
Cell Proliferation in FBAE Cells 
bFGF has been shown to induce cell proliferation and PA ac- 
tivity in bovine capillary endothelial cells (Moscatelli et al., 
1986; Presta et al., 1986). On this basis, preliminary experi- 
ments  were performed on GM  7373  cells to characterize 
their response to bFGE When subconfluent cultures of GM 
7373 cells were incubated for 24 h with different concentra- 
The Journal of Cell Biology, Volume  109, 1989  1878 tions of bFGF in the presence of 0.4 % FCS, an increase of 
cell number and cell-associated PA activity was observed 
(Fig. 1). The PA activity induced by bFGF has been identi- 
fied as of the urokinase-type PA by SDS-PAGE zymography 
(results not shown).  It is interesting to note that the EDso 
for the two responses is remarkably different, corresponding 
to 0.3 ng/ml and 3.0 ng/ml bFGF for the mitogenic activity 
and the PA-inducing activity, respectively. These data sug- 
gest that the PA-inducing activity of bFGF is not related to 
its mitogenic activity. Indeed, bFGF still stimulates PA activ- 
ity in GM 7373 cells whose mitogenic response to bFGF is 
abolished by co-incubation with mitomycin  C or by omission 
of FCS from the assay (results not shown). 
To characterize further the capacity of transformed FBAE 
cells to respond to different stimuli, we evaluated the capac- 
ity of TPA, EGF, and dibutyryl cyclic AMP (db-cAMP) to 
induce cell proliferation and PA activity in GM 7373 cells. 
AS shown in Fig. 1, all the molecules tested exerted a mito- 
genie response in these cells, but only TPA induced also an 
increase in PA activity. It must be pointed out that (a) both 
the mitogenic and the PA-inducing responses exerted by TPA 
were remarkably lower than those exerted by bFGF and (b) 
the PA-inducing activity of TPA was abolished when the mol- 
ecule was administered at concentrations >1 t~g/ml (results 
not shown), possibly as a consequence of down-regulation 
of PKC (see below).  For all the molecules tested, similar 
results were obtained on normal FBAE AG 7680 cells (data 
not shown).  These data indicate that among the mitogens 
tested only bFGF and TPA are able to induce PA activity in 
FBAE cells and that, in contrast with previous observations 
on adult bovine capillary and aortic endothelial cells (Gospo- 
darowicz et al., 1978; Doctrow and Folkman, 1987; Morris 
et al.,  1988),  both normal and transformed FBAE cells re- 
spond to the mitogenic activity of EGF and TPA. 
bFGF Induces PKC Activation in FBAE GM7373 Cells 
An 87-kD protein has been shown to be a major specific and 
widespread substrate for PKC (Blackshear et al.,  1986; Al- 
bert et al.,  1987).  PKC-dependent phosphorylation of this 
protein can be observed in experiments performed both on 
intact cells and on the cytosolic fraction of a variety of cell 
types (Rodriguez-Pena and Rozengurt, 1986; Blackshear et 
al.,  1986;  Mahadevan et  al.,  1987; Smith and Colburn, 
1988),  including endothelial cells  (Mackie et al.,  1986). 
Preliminary experiments were performed to assess whether 
this protein was present also in GM 7373 cells. Indeed, when 
a cytosolic fraction of GM 7373  cells was autophosphory- 
lated in the presence of the PKC activator TPA, the phos- 
phorylation of a band with an apparent molecular mass of 
87 kD was observed (data not shown). Moreover, the TPA- 
dependent phosphorylation of this protein was drastically re- 
duced in the cytosolic fraction of cells preincubated for 16 h 
with a high concentration (3 #g/ml) ofTPA (Maier, J. A. M., 
unpublished observations), a treatment which causes down- 
regulation of  PKC in several cell types, including endothelial 
cells  (Rodriguez-Pena  and  Rozengurt,  1984;  Rozengurt, 
1986; Wolfman et al., 1987; Uratsuji and DiCorleto, 1988). 
These data therefore indicate that the 87-kD protein repre- 
sents a major PKC substrate also in GM 7373 cells. 
On this basis, to evaluate the capacity of bFGF to induce 
PKC activation in GM 7373 cells, we assessed the effect of 
bFGF on the phosphorylation of the 87-kD protein in intact 
cells, bFGF treatment induces an increase in the phosphory- 
lation of several proteins, including an 87-kD protein (Fig. 
2 A).  The pattern of phosphorylation induced by bFGF is 
identical to that induced by TPA and it is abolished in PKC- 
deficient cells. Moreover, the kinetic of phosphorylation of 
the 87-kD protein induced by bFGF is very similar to that 
induced by TPA, both molecules causing a maximal induc- 
tion of the 87-kD phosphorylation within 1 rain from the be- 
ginning of  the stimulus (Fig. 2 B). A similar kinetic of induc- 
tion was observed also for the other proteins shown in Fig. 
2 A whose phosphorylation is stimulated both by bFGF and 
TPA (data not shown). It is interesting to note that bFGF in- 
duces a higher increase of 87-kD phosphorylation (fourfold 
increase) in respect to TPA (twofold increase). This differ- 
ence was observed both when the 87-kD  phosphorylation 
was quantified by soft-laser scanning of the autoradiography 
of the gel (Fig. 2 B) or by counting the radioactivity of the 
band excised from the gel (data not shown). In conclusion, 
these data suggest that bFGF induces activation of PKC in 
GM 7373 cells. 
Activation of PKC is paralleled by its translocation from 
the cytosol to the cell membrane (Nishizuka, 1986; Thomas 
et al., 1987). On this basis, to confirm the capacity ofbFGF 
to activate PKC in FBAE cells, we have measured PKC activ- 
ity in the solubilized membrane fraction of bFGF or TPA- 
treated cells. As shown in Fig. 3, both TPA and bFGF induce 
an increase in membrane PKC activity. As observed for 87- 
kD  phosphorylation, the increase is more pronounced in 
bFGF-treated cells than in cells stimulated with TPA.  No 
membrane-associated PKC activity was detectable in PKC- 
deficient cells stimulated with additional TPA or bFGF (Fig. 
3). Thus, our data indicate that bFGF induces activation of 
PKC in transformed FBAE cells. 
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Figure L Effect  of  different mitogens  on cell prolifera- 
tion and cell-associated PA activity in GM 7373 cells. 
Cells were seeded at 80,000 cells/cmL After 24 h, 
cultures were washed twice with serum-free medium 
and incubated in fresh medium containing 0.4% FCS 
and different concentrations of the mitogens tested. 
Cell number (o) and cell-associated PA activity (el 
were evaluated  after 24 h of incubation. The arrow in- 
dicates the PA activity in control cultures. Cell prolif- 
eration is expressed as percent of the proliferation ob- 
served in cells grown in 10% FCS. 
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in intact GM 7373 cells. (.4) Na- 
ive cultures (+ PKC) and cultures 
made PKC-deficient by 16 h incu- 
bation with 3/~g/ml TPA (- PKC) 
were  incubated  for 3  h  with 50 
pCi/ml  32E. Then,  cells  were 
treated  for  5  min  with  solvent 
control (c.),  100 ng/ml TPA,  or 
100 ng/ml bFGF. Cells were ex- 
tracted  and  all  the  1V_A-precip- 
itable  material  of  each  sample 
was run  on SDS  8%  polyacryl- 
amide gel.  Similar  results  were 
obtained in three independent ex- 
periments.  (B)  Naive  cultures 
were  incubated  for 3  h  with  50 
#Ci/ml  32E. Then,  cells  were 
treated  for  the  times  indicated 
with  100 ng/ml TPA (o) or with 
100 ng/ml bFGF (o). Cells were 
extracted  and  all  the  TCA-pre- 
cipitable material of each sample 
was run as in A. 87-kD phosphor- 
ylation was quantified by soft-laser scanning of the autoradiography of the gel.  Values  are shown as fold increase in respect to cultures 
treated with solvent control. Each point represents a single determination. Similar results were obtained in three independent experiments. 
The Mitogenic Activity of bFGF Depends 
on PKC Activity 
Long-term treatment with high concentrations of TPA results 
in down-regulation  of PKC  in  several cell types,  including 
endothelial  cells  (Rodriguez-Pena  and  Rozengurt,  1984; 
Rozengurt,  1986; Wolfman et al.,  1987; Uratsuji and DiCor- 
leto,  1988).  Accordingly,  we have observed that  16-h treat- 
ment with  3  #g/ml  TPA down-regulates  PKC  in GM 7373 
cells  (see above).  Therefore,  to assess  the  role of PKC  in 
mediating  the  mitogenic  and  the  PA-inducing  activity  of 
bFGF  in  transformed  FBAE  cells,  we  have  measured  the 
effect of bFGF on cell proliferation and PA activity in PKC- 
deficient cells. As shown in Fig. 4, down-regulation of PKC 
completely abolishes the mitogenic activity of bFGF but it 
does not affect its PA-inducing activity. As expected, instead, 
down-regulation  of PKC  completely abolishes  both the  in- 
crease in PA activity and the increase in cell number induced 
by TPA.  However,  PKC-deficient cells fully respond to the 
proliferative stimulus exerted by serum, EGE or db-cAMP, 
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Figure 3. PKC activity in GM 7373 
cell membranes. Naive cultures (t~) 
and PKC-deficient cultures ([]) were 
incubated  for  5  min  with  solvent 
control,  10 ng/ml TPA, or 30 ng/ml 
bFGE  Then,  detergent-solubilized 
membrane fractions  were  prepared 
and assayed for PKC activity as de- 
scribed  in  Materials  and  Methods. 
.~  Each value is the mean of two deter- 
bF6F  minations in triplicate. 
thus indicating that the lack of mitogenic response of PKC- 
deficient cells to bFGF and TPA is specific for these mole- 
cules.  These data therefore suggest that the mitogenic activ- 
ity of bFGF, but not its PA-inducing activity, is mediated by 
PKC. 
1-(5-isoquinolinesulfonyl)-2-methylpeperazine  dihydro- 
chloride (H-7) is an inhibitor of PKC and it has been shown 
to inhibit  several PKC-dependent  responses when adminis- 
tered to cultured cells (Kawamoto and Hidaka,  1984; Inagaki 
et al.,  1985;  Hidaka and  Hagiwara,  1987).  Moreover,  H-7 
inhibits the PKC-dependent 87-kD phosphorylation induced 
by TPA in the cytosolic fraction of GM 7373  cells  (Maier, 
J. A.  M.,  unpublished observations).  On this basis, to con- 
firm the role of PKC in mediating the mitogenic activity of 
bFGF, we have measured cell proliferation of GM 7373 cells 
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Figure 4. Effect of PKC deprivation on cell proliferation and PA ac- 
tivity in GM 7373 cells. Naive cultures ([]) and PKC-deficient cul- 
tures (D) were incubated in fresh medium containing 10% FCS or 
0.4% FCS added with solvent control (c.), 10 ng/ml TPA, 30 ng/ml 
bFGF, 30 ng/ml EGF, or 10  -s M db-cAMP.  After 16 h, cell number 
and cell-associated PA activity were determined. Cell proliferation 
is expressed as percent of the proliferation observed in naive cells 
grown in  10%  FCS. 
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mitogenic activity of bFGF, as well as that exerted by TPA, 
but not that exerted by serum (Fig. 5 A). The inhibition of the 
mitogenic activity of bFGF by H-7 was dose-dependent (Fig. 
5  B) with an IDs0 equal to 6  +  2  /zM  (n  =  5),  identical 
to the K~ value of this compound for PKC (Hidaka et al., 
1984).  However, as observed in PKC-deficient cells,  cells 
treated with H-7 still respond to bFGF in terms of PA activity 
(Fig. 5 B), further suggesting that the PA-inducing activity 
of bFGF in GM 7373 cells is independent from PKC. 
bFGF and PKC Activation in Normal 
FBAE AG 7680 Cells 
In contrast with our findings on transformed FBAE GM 7373 
cells,  PKC  activation  exerted  by  phorbol  ester  has  been 
shown to inhibit or to unaffect cell proliferation in adult bo- 
vine capillary or aortic endothelial cells (Doctrow and Folk- 
man, 1987;  Morris et al.,  1988). To rule out the possibility 
that the positive modulation of cell proliferation exerted by 
PKC in GM 7373 cells depends upon their transformed sta- 
res, we evaluated the role of PKC in the transduction of bFGF 
activity in normal FBAE AG 7680 cells. AG 7680 cells re- 
spond to TPA and bFGF with an increase in cell number and 
cell-associated PA activity (see above). AG 7680 ceils prein- 
cubated for 16 h with 3 #g/ml TPA are still able to respond 
to bFGF with an increase in PA activity, but not with an in- 
crease in cell proliferation. TPA-pretreatment, instead, com- 
pletely abolishes the mitogenic and the PA-inducing activity 
of additional TPA also in AG 7680 cells, without affecting the 
mitogenic activity of EGF and FCS (data not shown). Thus, 
these data indicate that PKC activation positively modulates 
the mitogenic but not the PA-inducing activity of bFGF also 
in normal FBAE cells and suggest that PKC might exert a 
different modulation of cell proliferation in fetal in respect 
to adult bovine aortic endothelial cells. 
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Figure 5. Effect of the PKC inhibitor H-7 mitogenic and PA-inducing 
activity of bFGE (A) GM 7373 cells were incubated in fresh medi- 
um containing  10% FCS or 0.4% FCS added with 30 ng/ml bFGF 
or 10 ng/ml TPA (t2). Half of the cultures received also 10 pM I-I-7 
(D). After 24 h, cell number was determined.  Cell proliferation is 
expressed as percent of the proliferation observed in cells grown in 
10% FCS with no addition.  (B) GM 7373 cells were incubated in 
fresh medium containing 0.4 % FCS and 30 ng/ml bFGF in the pres- 
ence of increasing concentrations  of H-7. After 24 h, cell number 
(o) and cell-associated  PA activity  (o) were determined.  Values 
are expressed as percent of the activity exerted by 30 ng/ml bFGF 
in the absence of H-7. No modification of cell number and cell- 
associated PA activity was induced by H-7 in control untreated cul- 
tures. 
bFGF Induces Ca  z÷ Influx in FBAE Cells 
In fibroblasts and in epithelial  lens cells,  bFGF  has been 
shown to cause an ir~crease in the cytoplasmic free Ca  2+ that 
is strictly dependent upon the presence of calcium in the ex- 
ternal  medium  (Magnaldo  et  al.,  1986;  Moenner  et  al., 
1987). Therefore, we investigated whether bFGF was able to 
elicit Ca  2÷ influx also in GM 7373  cells.  To this purpose, 
we measured the uptake of 45Ca in GM 7373  cells treated 
with bFGE The ionophore A23187  was used as a positive 
control. As shown in Fig. 6 A,  100 ng/ml bFGF induces a 
rapid increase of Ca  2+ uptake, comparable to that exerted by 
A23187.  The increase of Ca  2÷ uptake was dose dependent, 
with a half-maximal stimulation at 3 ng/ml bFGF (Fig. 6 B). 
Similar  results  were obtained  also  in  PKC-deprived cells 
(data not shown). The uptake was completely abolished by 
5-min preincubation with 1 mM EGTA (results not shown). 
These data therefore indicate that bFGF is able to induce a 
Ca  2÷ influx in naive and PKC-deprived GM 7373 cells. Ca  ~÷ 
influx  was observed also  in  normal  FBAE AG 7680  cells 
treated with  100 ng/ml bFGF (results not shown). 
The PA-inducing Activity of bFGF Depends 
on Ca  2÷ Influx 
PKC-deficient and H-7-treated FBAE cells still respond to 
bFGF with an increase of PA activity (see above), suggesting 
that the PA-inducing activity of bFGF does not depend on 
PKC. Since calcium is an important intracellular signal (Ras- 
mussen,  1986) and since bFGF induces Ca  2+ influx with a 
dose-response similar to that observed for the induction of 
PA activity, we investigated the role of external calcium in 
mediating the PA-inducing activity of bFGE As a prelimi- 
nary  experiment,  we  assessed  whether  a  Ca  2÷ influx  was 
sufficient to elicit an increase of PA activity in GM 7373 
cells. Indeed, 30 ng/ml of the calcium ionophore A23187 in- 
duces a threefold increase in PA activity. The effect is dose- 
dependent with a half-maximal stimulation at 10 ng/ml. No 
significant effect is instead exerted by A23187 on GM 7373 
cell proliferation (results not shown). These data therefore 
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Figure 6. Ca  2+ influx in GM 7373 cells. (A) 35-ram dish cultures 
were incubated in fresh medium containing 0.4%  FCS for 16 h. 
Then, cells were incubated in serum-free medium containing 2 tzCi/ 
m145Ca and no additions (A), 100 ng//ml bFGF (o), or 200 ng/ml 
A23187 (o). At the times indicated, cells were washed and intra- 
cellular  'sCa was counted by liquid scintillation  spectrometry  as 
described in Materials and Methods. Values are the mean +  SEM 
of three determinations.  (B) GM 7373 cells  were incubated  for 
2 min in serum-free medium containing 2 ~Ci/ml 45Ca and differ- 
ent amounts  of bFGE  Intraceilular  4Sea was evalnated as in A. 
Values are the mean  :t: SEM of three determinations.  Similar re- 
sults were obtained in three independent experiments. 
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Figure 7. Effect of EGTA on 
mitogenic and PA-inducing ac- 
tivity of bFGF in GM  7373 
cells.  Subconfluent  cultures 
were incubated in fresh medi- 
um with 0.4% FCS containing 
no additions (c.) or 100 ng/ml 
bFGE in the absence ((3) or 
in the presence ([]) of 1 mM 
EGTA. After 24 h, cell num- 
ber and cell-associated PA ac- 
tivity  were determined.  Cell 
proliferation  is  expressed  as 
percent of the proliferation ob- 
served in cells grown in 10% 
FCS with no additions. 
suggest that calcium uptake might be an event sufficient to 
stimulate PA activity in GM 7373 cells. 
To evaluate whether calcium uptake was responsible for the 
PA-inducing activity of bFGF, GM 7373 ceils were treated 
with bFGF in the presence of 1 mM EGTA. As shown in Fig. 
7, PA-inducing activity of bFGF was completely inhibited in 
these experimental conditions. GM 7373 cells, however, still 
responded to bFGF with an increase in cell number com- 
parable to that observed in cells maintained in the regular 
medium,  indicating that removal of free-calcium from the 
medium is not harmful for these cells in our experimental 
conditions. Inhibition of the PA-inducing activity of bFGF 
was observed also in PKC-deprived cells treated with bFGF 
in the presence of 1 mM EGTA or in naive cells stimulated 
with bFGF in a calcium-free medium (data not shown). 
Discussion 
Here we have shown that bFGF induces activation of PKC 
in transformed FBAE cells. This has been demonstrated by 
the capacity of bFGF to increase the phosphorylation of a 
major specific 87-kD PKC substrate in intact GM 7373 cells 
and  to  increase membrane-bound  calcium,  phospholipid- 
dependent PKC activity.  Similar results were obtained in 
parallel experiments where GM 7373 cells were treated with 
the phorbol ester TPA. Interestingly, the increase of 87-kD 
phosphorylation and of membrane-bound PKC activity in- 
duced by bFGF is higher than that induced by TPA. It is 
tempting to relate these findings with the higher mitogenic 
potency of bFGF in respect to TPA in FBAE cells. PKC is 
known to exist in different forms derived from distinct genes. 
These forms differ in terms of  enzymological characteristics, 
tissue expression, and intracellular localization (Nishizuka, 
1988). Recently, the presence of different forms of PKC in 
endothelial cells has been proposed (Uratsuji and DiCorleto, 
1988). It is then possible that in FBAE cells bFGF and TPA 
may activate different PKCs capable of eliciting a different 
mitogenic response.  Further experiments are necessary to 
assess this hypothesis. 
The capacity of bFGF to induce PKC activation, evaluated 
as  87-kD phosphorylation, has been already reported for 
Swiss 3T3 and 3T3-L1 fibroblasts (Tsuda et al., 1985; Black- 
shear et al.,  1985; Kaibuchi et al.,  1986). On the contrary, 
PKC activation, evaluated as down-regulated of EGF recep- 
tors, was not detectable in CCL39 hamster fibroblasts treated 
with bFGF (Magnaldo et al.,  1986). It is therefore possible 
to hypothesize that the demonstration of the capacity of bFGF 
to activate PKC might depend on the cell type under investi- 
gation and/or on the assay used. 
TPA induces cell proliferation in naive but not in PKC- 
deprived GM 7373 cells, thus indicating a positive role of 
PKC activation in the regulation of cell proliferation in these 
cells. Accordingly, activation of PKC appears to be responsi- 
ble for the mitogenic activity of bFGF. Indeed, PKC-deprived 
cells do not respond to bFGF in terms of cell proliferation. 
Moreover, the mitogenic activity of bFGF is inhibited when 
the cells are incubated in the presence of the PKC inhibitor 
H-7. The IDs0 of H-7 was 6 ~M, equal to the K~ value of this 
compound for PKC (Hidaka et al., 1984). Thus, the possibil- 
ity that the inhibitory effect exerted by H-7 on the mitogenic 
activity of bFGF might depend upon an inhibition of protein 
kinase(s) different from PKC (Hidaka et al.,  1984) appears 
to be unlikely. PKC-deprived or H-7-treated cells were still 
able to respond to different mitogens, e.g., EGF, db-cAMP, 
or serum, indicating that the lack of mitogenic response to 
bFGF and TPA was indeed due to the down-regulation or in- 
hibition of PKC activity and not to an impairment of the ca- 
pacity of these cells to proliferate. Similar results were ob- 
tained with normal FBAE AG 7680 cells, thus indicating that 
these findings are not due to the transformed status of GM 
7373 cells. 
The positive role of PKC activation in the regulation of  cell 
proliferation of FBAE  cells  is  in  contrast  with  previous 
reports on the lack of effect or on the inhibitory effect of 
phorbol ester on proliferation in adult bovine endothelial 
cells (Doctrow and Folkman,  1987;  Morris et al.,  1988). 
Here,  we  have  shown  that  both  normal  and  transformed 
FBAE cells respond to TPA administration with an increase 
in cell number and that this increase is prevented in PKC 
down-regulated cells. In parallel experiments we have con- 
firmed the inhibitory effect of TPA on proliferation of adult 
bovine aortic endothelial cells (data not shown). It is there- 
fore possible to hypothesize that the control exerted by PKC 
activation on endothelial cell proliferation might change dur- 
ing ontogenetic development. This appears to be of particu- 
lar relevance in experiments aimed to characterize the role 
exerted by PKC in endothelial cells during angiogenesis, es- 
pecially when in vivo assays on chicken embryo chorioallan- 
toic membrane are used. Recently, an apparent discrepancy 
between the capacity of phorbol esters to induce angiogene- 
sis in the chorioallantoic membrane assay and the lack of 
mitogenic activity of these molecules in cultured adult bo- 
vine capillary endothelial cells has been reported (Morris et 
al.,  1988). On the basis of our results, the different degree 
of ontogenetic development between the endothelial cells of 
the two biological assays might account for this discrepancy. 
bFGF can still cause an increase of PA activity in GM 7373 
cells treated with the PKC inhibitor H-7 or in cells rendered 
PKC-deficient by  preincubation  with  high  concentrations 
of TPA. Several criteria indicate that PKC was  effectively 
down-regulated in TPA-pretreated cells. In these cells: (a) no 
PKC-dependent phosphorylation of the 87-kD substrate was 
observed in the cytosolic fraction or in intact cells treated 
with bFGF or additional TPA; (b) no increase in membrane- 
associated PKC activity was observed after treatment with 
bFGF or additional TPA; (c) no stimulation of cell prolifera- 
tion was elicited by bFGF or additional TPA, as well as by 
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(data not shown).  In agreement with these observations in 
transformed GM 7373 cells, bFGF retains  its PA-inducing 
activity in normal AG 7680 cells pretreated  with high con- 
centrations of TPA or incubated with the growth factor in the 
presence of H-7 (data not shown). Thus, even though the ex- 
istence of down-regulation-resistant PKC(s) has been pro- 
posed (Kariya and Takai,  1987), our results strongly suggest 
that the PA-inducing  activity of bFGF, at variance with its 
mitogenic  activity,  is triggered by an H-7  resistant,  PKC- 
independent pathway  in FBAE cells. 
Several  lines of evidence  indicate that extracellular cal- 
cium is involved in the increase of PA activity induced by 
bFGF in FBAE cells: (a) the calcium ionophore A23187 in- 
duces an increase of PA activity;  (b) bFGF induces a 'sCa 
influx similar to that exerted by A23187 in naive and PKC- 
deficient cells; (c) the concentration of bFGF necessary to 
elicit a half-maximal increase of Ca  2÷ uptake is identical to 
that necessary to induce a half-maximal increase of PA activ- 
ity;  (d)  1 mM  EGTA  completely  inhibits  the 45Ca influx 
and the increase of PA activity induced by bFGF in naive and 
PKC-deprived cells. However, it must be pointed out that the 
increase of PA activity which follows A23187 administration 
is remarkably lower than that observed in bFGF-treated cells, 
suggesting that Ca  2+ influx might be only part of the intra- 
cellular mechanism  triggering  the  PA-inducing  activity  of 
bFGF. Similar conclusions have been drawn for the ornithine 
decarboxylase-inducing  activity of bFGF in PKC-deprived 
fibroblasts (Hovis et al.,  1986). 
In conclusion, our results indicate that bFGF induces at 
least two distinct intracellular signaling pathways  in FBAE 
cells: a PKC-dependent pathway responsible of its mitogenic 
activity  and a calcium-dependent,  PKC-independent  path- 
way responsible for its PA-inducing  activity. 
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